AUA 2019: Characterization of the “End Stage Bladder” in Chronic Cystitis
There were 75 patients with chronic cystitis were identified and after exclusions, 30 were included in the study from 2008-2018, 75 patients with chronic cystitis were identified and after exclusions, 30 were included in the study. Most patients were female (n=25, 83%) and Caucasian (n=27, 90%) and had never used tobacco (n=20, 67%). The most frequent comorbidities included asthma (n=19, 63%), anemia (n=17, 57%) and hypertension (n=18, 60%).
The median age of onset of bladder symptoms was 63 years (IQR 47,68) and the primary presenting symptom was most often incontinence (n=9, 30%), recurrent urinary tract infections (n=8, 27%) or Urgency/frequency (n=7 23%). The median maximum bladder capacity was 67 mL (IQR 30, 150). At presentation, imaging showed hydronephrosis in 33% (n=10) and VUR in 40% (n=12). Bladder pathology revealed inflammation in most (n=22, 73%), followed by ulcerated (n=15, 50%) or denuded epithelium (n=10, 33%); Eosinophilic cystitis was rare (n=4, 13%). Median follow-up was 18 months (IQR 8,48). At time of the most recent clinical encounter, 25 (83%) patients had undergone urinary diversion. The median time from presentation to urinary diversion was 2 years (IQR 1,8). Age at onset was found to be correlated to proceeding to urinary diversion (p=0.01), however no significant correlation was found between need for urinary diversion and the length of symptom duration or bladder capacity.
In this cohort of patients with End Stage Chronic Cystitis, 83% ultimately required urinary diversion within 2 years of symptom onset. Age at onset was correlated with need for urinary diversion. Larger cohort studies are required to draw conclusions regarding factors predisposing to this severe phenotype
Presented by: Giulia Lane, MD Michigan Medicine, Department of Urology, Ann Arbor, Michigan
Written by: Bilal Farhan, MD, Clinical Instructor, Female Urology and Voiding Dysfunction, Department of Urology, University of California, Irvine @BilalfarhanMD at the American Urological Association's 2019 Annual Meeting (AUA 2019), May 3 – 6, 2019 in Chicago, Illinois